Showing results (11-20 of 932) with videos related to
Sort By:
Pageof 94
Neuroepidemiology|November 29, 2007
Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E statusKenneth Rockwood, Susan Howlett, John Fisk, et al.Current Alzheimer Research|April 5, 2016
Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer's DiseaseSultan DarveshChemico-Biological Interactions|September 1, 2012
Butyrylcholinesterase radioligands to image Alzheimer's disease brainSultan DarveshDementia and Geriatric Cognitive Disorders|August 25, 2010
An MRI-based semiquantitative index for the evaluation of brain atrophy and lesions in Alzheimer's disease, mild cognitive impairment and normal agingWei Chen, Xiaowei Song, Yunting Zhang, et al.Journal of Alzheimer'S Disease : JAD|October 6, 2011
An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up studyNingnannan Zhang, Xiaowei Song, Yunting Zhang, et al.Drugs of Today (Barcelona, Spain : 1998)|October 29, 2004
Butyrylcholinesterase, cholinergic neurotransmission and the pathology of Alzheimer's diseaseChangiz Geula, Sultan DarveshNeuroscience|May 2, 2015
Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse modelG Andrew Reid, Sultan DarveshThe Journal of Comparative Neurology|August 12, 2020
Distribution of acetylcholinesterase in the hippocampal formation of the Atlantic white-sided dolphin (Lagenorhynchus acutus)George Andrew Reid, Sultan DarveshThe Journal of Comparative Neurology|June 18, 2003
Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamusSultan Darvesh, David A HopkinsCellular and Molecular Neurobiology|April 19, 2003
Enantiomer effects of huperzine A on the aryl acylamidase activity of human cholinesterasesSultan Darvesh, Ryan Walsh, Earl MartinPageof 94